Lucas Di Meglio
ORCID: 0000-0002-5158-8612Also affiliated with Université Paris Cité, Sorbonne Université, Sorbonne Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Lariboisière, Pitié-Salpêtrière Hospital, Paris Cardiovascular Research Center, FHU Neurovasc, Optimisation Thérapeutique en Neuropsychopharmacologie, Marqueurs cardiovasculaires en situation de stress
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 2 papers. Top paper: “Multicenter randomized trial assessing efficacy and safety of aerosolized dornase Alfa in COVID-19 ARDS”.
Lucas Di Meglio, Chloé Le Cossec, Benoit Ho-Tin-Noé, Mialitiana Solo Nomenjanahary, Jessica Guillaume +11 more
Roberto Negro, Shoichi Fukui, Lucas Di Meglio, Karen Aymonnier, Long Chu +11 more